This OHDSI network study assesses the comparative effectiveness and safety among treatments administered during hospitalization and prior to intensive services. It also assesses the comparative effectiveness and safety among treatments administered after COVID-19 positive testing or diagnosis in the outpatient setting without prior hospitalization.
1
stars
1
forks
source link
Subgroup by cohorts from ScyllaCharacterization #6
The protocol requires that we assess the comparative effectiveness and safety among treatments administered after COVID positive testing and prior to hospitalization. To do this, we'll use the subgroupId == 2002 from the ScyllaCharacterization package.
The call to ScyllaCharacterization::createBulkSubgroupFromCohorts will take all of the target cohorts and subset them by all of the subgroup cohorts as defined in: CohortsToCreateSubgroup.csv. This will include the subgroupId == 2002 but also many others so let me know if you have any questions/concerns.
The protocol requires that we assess the comparative effectiveness and safety among treatments administered after COVID positive testing and prior to hospitalization. To do this, we'll use the subgroupId == 2002 from the ScyllaCharacterization package.
The call to
ScyllaCharacterization::createBulkSubgroupFromCohortswill take all of the target cohorts and subset them by all of the subgroup cohorts as defined in: CohortsToCreateSubgroup.csv. This will include the subgroupId == 2002 but also many others so let me know if you have any questions/concerns.